STOCK TITAN

Ra Medical Systems to Participate in A.G.P.’s Virtual Healthcare Symposium

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Ra Medical Systems, Inc. (NYSE: RMED) will participate in A.G.P.’s Virtual Healthcare Symposium on November 19, 2020. Management will engage in one-on-one meetings with interested investors. The company specializes in excimer laser systems for treating vascular and dermatological diseases. Their DABRA excimer laser system is FDA-cleared for treating chronic total occlusions, while the Pharos system targets skin conditions like psoriasis. Both systems are manufactured at their ISO-certified facility in Carlsbad, California.

Positive
  • None.
Negative
  • None.

CARLSBAD, Calif.--()--Ra Medical Systems, Inc. (NYSE: RMED) , a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, announces that management will participate in A.G.P.’s Virtual Healthcare Symposium. This event, which features one-on-one meetings, is being held Thursday, November 19, 2020.

Ra Medical management will be available for one-on-one meetings. Interested investors should contact Ra Medical President Jeffrey Kraws at jkraws@ramed.com or Jody Cain at jcain@lhai.com.

About Ra Medical Systems

Ra Medical Systems commercializes excimer lasers and catheters for the treatment of vascular and dermatological diseases. In May 2017 the DABRA excimer laser system received FDA 510(k) clearance in the U.S. for crossing chronic total occlusions, or CTOs, in patients with symptomatic infrainguinal lower extremity vascular disease with an intended use for ablating a channel in occlusive peripheral vascular disease. The Pharos excimer laser system is FDA-cleared and is used as a tool in the treatment of psoriasis, vitiligo, atopic dermatitis and leukoderma. DABRA and Pharos are both based on Ra Medical’s core excimer laser technology platform and deploy similar mechanisms of action. Ra Medical manufactures DABRA and Pharos excimer lasers and catheters in a 32,000-square-foot facility located in Carlsbad, Calif. The vertically integrated facility is ISO 13485 certified and is licensed by the State of California to manufacture sterile, single-use catheters in controlled environments.

Contacts

At the Company:
Jeffrey Kraws
President, Ra Medical Systems
760-496-9008
jkraws@ramed.com

Investors:
LHA Investor Relations
Jody Cain
310-691-7100
jcain@lhai.com

FAQ

When will Ra Medical participate in A.G.P.’s Virtual Healthcare Symposium?

Ra Medical will participate in A.G.P.’s Virtual Healthcare Symposium on November 19, 2020.

What is the focus of Ra Medical Systems?

Ra Medical Systems focuses on commercializing excimer laser systems to treat vascular and dermatological diseases.

What FDA clearances do Ra Medical’s products have?

The DABRA excimer laser system is FDA-cleared for treating chronic total occlusions, and the Pharos system is FDA-cleared for treating skin conditions like psoriasis.

Where is Ra Medical Systems' manufacturing facility located?

Ra Medical Systems manufactures its excimer lasers and catheters in Carlsbad, California.

Who can investors contact for one-on-one meetings with Ra Medical management?

Interested investors can contact Jeffrey Kraws or Jody Cain for one-on-one meetings.

Ra Medical Systems, Inc.

NYSE:RMED

RMED Rankings

RMED Latest News

RMED Stock Data

3.84M
4.60M
36.85%
11%
1.26%
Medical Devices
Healthcare
Link
United States
Fort Mill